Effect of traumatic imagery on cerebrospinal fluid dopamine and serotonin metabolites in posttraumatic stress disorder

Journal of Psychiatric Research

Volumn 47, Issue 7, 2013, Pages 995-998

  Geracioti, Thomas D ^a,b   Jefferson Wilson, Lena ^a,b   Strawn, Jeffrey R ^a,b   Baker, Dewleen G ^c   Dashevsky, Boris A ^a,b   Horn, Paul S ^d   Ekhator, Nosakhare N ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

5 Hydroxyindoleacetic acid (5 HIAA); Anxiety; Cerebrospinal fluid (CSF); Dopamine; Homovanillic acid (HVA); Post traumatic stress disorder (PTSD); Serotonin

Indexed keywords

DOPAMINE; HOMOVANILLIC ACID; SEROTONIN;

ADULT; ANXIETY; ARTICLE; BLOOD PRESSURE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; HEART RATE; HUMAN; IMAGERY; MALE; MENTAL STRESS; MOOD; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; TRAUMATIC IMAGERY;

EID: 84877101010     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.01.023     Document Type: Article

References (35)

1. Aitken R.C., Zeally A.H. Measurement of mood. British Journal of Hospital Medicine 1970, 4:215-244.
2. Arnsten A.F.T. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology 2006, 31:2376-2383.
3. Bailey J.N., Goenjian A.K., Noble E.P., Walling D.P., Ritchie T., Goenjian H.A. PTSD and dopaminergic genes DRD2 and DAT in multigenerational families exposed to the Spitak earthquake. Psychiatry Research 2010, 178:507-510.
4. Becker M.E., Hertzberg M.A., Moore S.D., Dennis M.F., Bukenya D.S., Beckham J.C. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology 2007, 27:193-197.
5. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., et al. The development of a clinician-administered PTSD Scale. Journal of Traumatic Stress 1995, 8:75-90.
6. Brady K., Pearlstein T., Asnis G.M., Baker D., Rothbaum B., Sikes C.R., et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Journal of the American Medical Association 2000, 283:1837-1844.
7. Broekman B.F., Olff M., Boer F. The genetic background to PTSD. Neuroscience & Biobehavioral Reviews 2007, 31:348-362.
8. Cabib S., Puglisi-Allegra S. The mesoaccumbens dopamine in coping with stress. Neuroscience & Biobehavioral Reviews 2012, 36:79-89.
9. Daly O.E. The use of stimulants in the treatment of post traumatic stress disorder: case report. Human Psychopharmacology 2000, 15:295-300.
10. Davidson J.R., Rothbaum B.O., van der Kolk B.A., Sikes C.R., Farfel G.M. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry 2001, 58:485-492.
11. Geracioti T.D., Baker D.G., Kasckow J.W., Mulchahey J.J., Strawn J.R., Dashevsky B.A., et al. Effect of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder. Psychoneuroendocrinology 2008, 33:416-424.
12. Geracioti T.D., Keck P.E., Ekhator N.N., West S.A., Baker D.G., Hill K.K., et al. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Biological Psychiatry 1998, 44:228-233.
13. Geracioti T.D., West S.A., Baker D.G., Hill K.K., Ekhator N.N., Wortman M.D., Keck P.E., et al. Low CSF concentration of a dopamine metabolite in tobacco smokers. American Journal of Psychiatry 1999, 156:130-132.
14. Geranton S.M., Heal D.J., Stanford S.C. Differences in the mechanisms that increase noradrenaline eflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus. British Journal of Pharmacology 2003, 139:1441-1448.
15. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 1960, 23:56-62.
16. Hamner M.B., Faldowski R.A., Ulmer H.G., Frueh B.C., Huber M.G., Arana G.W. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. International Clinical Psychopharmacology 2003 Jan, 18(1):1-8.
17. Hamner M.B., Robert S. Emerging roles for atypical antipsychotics in chronic post-traumatic stress disorder. Expert Review of Neurotherapeutics 2005, 5:267-275.
18. Han D.D., Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacology 2006, 3:6.
19. Hertzberg M.A., Feldman M.E., Beckham J.C., Kudler H.S., Davidson J.R. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Annals of Clinical Psychiatry 2000, 12:101-105.
20. Hill K.K., West S.A., Ekhator N.N., Bruce A.B., Wortman M.D., Baker D.G., et al. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid. Neuroscience Letters 1999, 276:25-28.
21. Houlihan D.J. Psychostimulant treatment of combat-related posttraumatic stress disorder. Journal of Psychopharmacology 2011, 25:1568-1572.
22. Kopin I.J., White J.H., Bankiewicz K. A new approach to biochemical evaluation of brain dopamine metabolism. Cellular and Molecular Neurobiology 1988, 8:171-179.
23. Krystal J.H., Rosenheck R.A., Cramer J.A., Vessicchio J.C., Jones K.M., Vertrees J.E., et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD. A randomized trial. Journal of the American Medical Association 2011, 306:493-502.
24. Kuczenski R., Segal D. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biological Psychiatry 2005, 57:1391-1396.
25. Marshall R.D., Beebe K.L., Oldham M., Zaninelli R. Efficacy and safety of paroxetine for chronic PTSD: a fixed-dose, placebo-controlled study. American Journal of Psychiatry 2001, 158:1982-1988.
26. Raiteri M., Bertollini A., Angelini F., Levi G. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. European Journal of Pharmacology 1975, 34:189-195.
27. Rothbaum B.O., Killeen T.K., Davidson J.R., Brady K.T., Connor K.M., Heekin M.H. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. Journal of Clinical Psychiatry 2008, 69:520-525.
28. Santamaria A., Arias H.R. Neurochemical and behavioral effects elicited by bupropion and diethylpropion. Behavioural Brain Research 2010, 211:132-139.
29. Stahl S.M., Pradko J.F., Haight B.R., Modell J.G., Rockett C.B., Learned-Coughlin S. A review of the neuropharmacology of buproprion, a dual norepinephrine and dopamine reuptake inhibitor. Primary Care Companion to The Journal of Clinical Psychiatry 2004, 6:159-166.
30. Stein M.B., Kline N.A., Matloff J.L. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. American Journal of Psychiatry 2002, 159:1777-1779.
31. Strawn J.R., Ekhator N.N., Anthenelli R.M., Baker D.G., Maxwell R.A., Hill K.K., et al. Intra- and inter-individual relationships between central and peripheral serotonergic activity in humans: serial cerebrospinal fluid studies. Life Sciences 2002, 71:1219-1225.
32. Strawn J.R., Ekhator N.N., Geracioti T.D. In-use stability of monoamine metabolites in cerebrospinal fluid. Journal of Chromatography B 2001, 760:301-306.
33. Valente N.L., Vallada H., Cordeiro Q., Miguita K., Bressan R.A., Andreoli S.B., et al. Candidate-gene approach in posttraumatic stress disorder after urban violence: association analysis of the genes encoding serotonin transporter, dopamine transporter, and BDNF. Journal of Molecular Neuroscience 2011, 44:59-67.
34. van der Kolk B.A., Dreyfuss D., Michaels M., Shera D., Berkowitz R., Fisler R., et al. Fluoxetine in posttraumatic stress disorder. Journal of Clinical Psychiatry 1994, 55:517-522.
35. Zohar J., Amital D., Miodownik C., Kotler M., Bleich A., Lane R.M., et al. Double-blind, placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. Journal of Clinical Psychopharmacology 2002, 22:190-195.